More importantly, a fracture that doesnt heal properly can leave patients with an inability to return to their normal day-to-day activities
Topical concentrations reported in studies and commercial formulations vary, with published and commercial use spanning a broad range (typically 0.1% to 5%), applied once or twice daily to the skin or scalp [2]
It is unclear why directionality would vary between studies, although we note these studies were performed in specific disease contexts, and are in substantially smaller samples
AOD-9604s key advantage is extensive human safety data from clinical trials involving nearly 900 participants, establishing excellent tolerability
Methods In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews (PRISMA-ScR) [8], we systematically searched three electronic databases: MEDLINE, PubMed, and the Cochrane Database for Systematic Reviews and Cochrane Central Register for Controlled Trials for relevant articles from inception until September 2023